Latest filing published 20 Apr 2026 for RxSight, Inc., €44k. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Ilya Goldshleger in RxSight, Inc., where the filings describe the role as senior executive. Between 5 August 2021 and 17 April 2026, the trades on record add up to 29 filings.
The open-market side counts 1 purchase for €12k alongside 1 sale for €41k. On balance, insiders were net sellers of €28k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 27 option exercises.
The record was last updated on 20 April 2026 with an option exercise (€44k) in RxSight, Inc. The last purchase on record was published on 6 August 2021, which is 1,899 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations